Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.
The effect of viloxazine (150-300 mg daily for 21 days) on plasma phenytoin levels at steady state was examined in 10 epileptic patients stabilised on a fixed phenytoin dosage. After starting viloxazine treatment, plasma phenytoin concentrations increased by 37% on average (range 7-94%) from a mean...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Neurol Neurosurg Psychiatry |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMJ Publishing Group
1992
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC488975/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1538217/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.55.2.126 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
